Zeiss’ Visumax 800 With Smile Pro Software Approved by FDA

Zeiss Medical Technology announced that the FDA has approved the Visumax 800 With Smile Pro software for surgically treating nearsightedness, with or without astigmatism. This latest generation of femtosecond lasers from Zeiss enters the United States market as the technology is being broadly adopted in Asia and Europe, noted the company.

According to Zeiss, the Visumax 800 with Smile Pro software enables faster treatment, creating the lenticule in < 10 seconds because of a faster laser pulse repetition rate of 2 MHz. An additional of the shorter procedure time is a potential reduction of stress for surgeons and their patients.

The Zeiss femtosecond laser also provides greater flexibility for the surgeon and patient, with a smaller footprint and compatibility with a variety of patient beds, adapting to the clinical environment to provide cutting-edge technology without compromise, noted the company.

Enhancements of the Visumax 800 with Smile Pro software include the CentraLign centration aid, a computer-controlled function for easy centration; the OcuLign cyclotorsion adjustment to help counter cyclotorsion that may occur; and Visulyze user nomograms to help surgeons collect and analyze patient data, while also providing detailed nomograms and enabling more control during every surgery.

“The Visumax 800 is a practice builder and allows surgeons to differentiate their practice from local competitors,” commented Luke Rebenitsch, MD, in the company’s press release. Dr. Rebenitsch is from ClearSight LASIK and 43Vision in Oklahoma City, Oklahoma.